Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure

Journal of Hypertension

Volumn 25, Issue 1, 2007, Pages 157-161

  Hering, Dagmara ^a   Zdrojewski, Zbigniew ^a   Król, Ewa ^a   Kara, Tomas ^b   Kucharska, Wiesława ^a   Somers, Virend K ^b   Rutkowski, Bolesław ^a   Narkiewicz, Krzysztof ^a,b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MAYO CLINIC   (United States)

Author keywords

Autonomic nervous system; Chemoreflexes; Renal failure; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OXYGEN; PLACEBO;

ADULT; AGE; AMBIENT AIR; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CHEMORECEPTOR REFLEX; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENDER; HUMAN; HYPEROXIA; HYPERTENSION; MALE; MORBIDITY; MUSCLE SPINDLE AFFERENT NERVE; NERVE CONDUCTION; OXYGEN BREATHING; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE;

EID: 33845368775     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3280102d92     Document Type: Article

References (31)

1. Koomans HA, Blankestijn PJ, Joles JA. Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 2004; 15:524-537.
2. Rump LC, Amann K, Orth S, Ritz E. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol Dial Transplant 2000; 15:1735-1738.
3. Campese VM, Krol E. Neurogenic factors in renal hypertension. Curr Hypertens Rep 2002; 4:256-260.
4. Tuncel M, Augustyniak R, Zhang W, Toto RD, Victor RG. Sympathetic nervous system function in renal hypertension. Curr Hypertens Rep 2002; 4:229-236.
5. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327:1912-1918.
6. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, et al. Sympathetic nerve activity in end-stage renal disease. Circulation 2002; 106:1974-1979.
7. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, et al. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999; 340:1321-1328.
8. Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J Am Soc Nephrol 2001; 12:2427-2433.
9. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105:1354-1359.
10. Amann K, Ritz C, Adamczak M, Ritz E. Why is coronary heart disease of uraemic patients so frequent and so devastating? Nephrol Dial Transplant 2003; 18:631-640.
11. Ye S, Ozgur B, Campese VM. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 1997; 51:722-727.
12. Ye S, Zhong H, Yanamadala V, Campese VM. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens 2002; 15:717-724.
13. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 1992; 262:E763-E778.
14. Matsukawa T, Gotoh E, Minamisawa K, Kihara M, Ueda S, Shionoiri H, Ishii M. Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans. Am J Physiol 1991; 261:R690-R696.
15. Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis 2002; 39:1-11.
16. Mallamaci F, Tripepi G, Maas R, Malatino L, Boger R, Zoccali C. Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease. J Am Soc Nephrol 2004; 15:435-441.
17. Kara T, Narkiewicz K, Somers VK. Chemoreflexes - physiology and clinical implications. Acta Physiol Scand 2003; 177:377-384.
18. Trzebski A, Tafil M, Zoltowski M, Przybylski J. Increased sensitivity of the arterial chemoreceptor drive in young men with mild hypertension. Cardiovasc Res 1982; 16:163-172.
19. Trzebski A. Arterial chemoreceptor reflex and hypertension. Hypertension 1992; 19:562-566.
20. Kubin L, Trzebski A, Lipski J. Split medulla preparation in the cat: arterial chemoreceptor reflex and respiratory modulation of the renal sympathetic nerve activity. J Auton Nerv Syst 1985; 12:211-225.
21. Honig A. Peripheral arterial chemoreceptors and reflex control of sodium and water homeostasis. Am J Physiol 1989; 26:R1282-R1302.
22. Brauer H, Gens A, Ledderhos C, Sanchez R, Schuster R, Quies W, Honig A. Cardiorespiratory and renal responses to arterial chemoreceptor stimulation by hypoxia or almitrine in men. Clin Exp Pharmacol Physiol 1996; 23:1021-1027.
23. Joles JA, Koomans HA. Causes and consequences of increased sympathetic activity in renal disease. Hypertension 2004; 43:699-706.
24. Orth SR, Amann K, Strojek K, Ritz E. Sympathetic overactivity and arterial hypertension in renal failure. Nephrol Dial Transplant 2001; 16 (Suppl 1):67-69.
25. DiBona GF. The sympathetic nervous system and hypertension: recent developments. Hypertension 2004; 43:147-150.
26. Neumann J, Ligtenberg G, Oey L, Koomans HA, Blankestijn PJ. Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure. J Am Soc Nephrol 2004; 15:2902-2907.
27. Strojek K, Grzeszczak W, Gorska J, Leschinger MI, Ritz E. Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy? J Am Soc Nephrol 2001; 12:602-605.
28. DiBona GF. Neural control of the kidney: past, present, and future. Hypertension 2003; 41:621-624.
29. Zazgornik J, Biesenbach G, Janko O, Gross C, Mair R, Brucke P, et al. Bilateral nephrectomy: the best, but often overlooked, treatment for refractory hypertension in hemodialysis patients. Am J Hypertens 1998; 11:1364-1370.
30. Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension 2004; 43:163-168.
31. ManciaG,Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999; 34:724-728.